Results 231 to 240 of about 425,151 (292)

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source

Population Pharmacokinetics of Ticagrelor during Veno‐Arterial ECMO in Acute Coronary Syndrome: Model‐Informed Dosing Simulations

Clinical Pharmacology &Therapeutics, EarlyView.
Although patients with acute coronary syndrome supported by veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) have a high risk of thrombosis and bleeding, antiplatelet pharmacology in this setting is not well defined. This prospective observational study investigated the population pharmacokinetics of ticagrelor and its active metabolite AR ...
Soyoung Kang, Kyoung Lok Min, Seungwon Yang, Jongsung Hahn, Dasohm Kim, Byung Hak Jin, Soon Uk Chae, Soo Kyung Bae, Jin Wi, Min Jung Chang   +9 more
wiley   +1 more source

A low-cost hematologic biomarker for evaluating peripheral arterial disease risk: Derived neutrophil-lymphocyte ratio in NHANES 1999-2004 adults. [PDF]

Medicine (Baltimore)
Liu Q, Wu X, Shi J.
europepmc   +1 more source

Secretopathies emerge as a new class of neurocristopathies

Developmental Dynamics, EarlyView.
Abstract Neural crest cells are a transient embryonic population of cells that give rise to a wide range of structures, including craniofacial cartilage and bone, peripheral neurons and glia, as well as components of the cardiac outflow tract, among others.
Amanda Teixeira, Cassandra Millet‐Boureima, Joshua A. Moore, Loydie A. Jerome‐Majewska   +3 more
wiley   +1 more source

Oxidized HDL status in hemodialysis patients with peripheral arterial disease: a pilot study. [PDF]

Arch Med Sci Atheroscler Dis
Kotani K, Matsubara D, Mukai H, Ogura M, Iwazu Y.   +4 more
europepmc   +1 more source

Procedural Utility, Reliability, and Success of Endovascular Intervention for Peripheral Arterial Disease Utilizing Transradial Access. [PDF]

J Soc Cardiovasc Angiogr Interv
Khraisat A, Abood Z, Mewissen MW, Osman M, Allaqaband SQ, Bajwa T, Jan MF.   +6 more
europepmc   +1 more source

The Use of Pressure Indices, Such as Fractional Flow Reserve, in Peripheral Arterial Disease-A Review of Current Literature and Potential Prospects. [PDF]

Vasc Endovascular Surg
Karia K, Al-Rekabi A, Suseeharan M, Bahl R, Hamady M.   +4 more
europepmc   +1 more source

The Role of High-Sensitivity Cardiac Troponin and Ischemia-Modified Albumin in Patients with Lower Extremity Peripheral Arterial Disease. [PDF]

Int J Mol Sci
Boc V, Blinc A, Boc A.
europepmc   +1 more source